These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36715049)

  • 21. Economic and epidemiological impact of dengue illness over 16 years from a public health system perspective in Brazil to inform future health policies including the adoption of a dengue vaccine.
    Godói IP; Da Silva LVD; Sarker AR; Megiddo I; Morton A; Godman B; Alvarez-Madrazo S; Bennie M; Guerra-Junior AA
    Expert Rev Vaccines; 2018 Dec; 17(12):1123-1133. PubMed ID: 30417706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study on active and passive epidemiological surveillance for dengue in five countries of Latin America.
    Sarti E; L'Azou M; Mercado M; Kuri P; Siqueira JB; Solis E; Noriega F; Ochiai RL
    Int J Infect Dis; 2016 Mar; 44():44-9. PubMed ID: 26836763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety Follow-up of a Dengue Vaccine When Administered Concomitantly with a Yellow Fever Vaccine in Healthy Toddlers in Colombia.
    Cortés M; López P; Márquez V; Cortes C; Toro E; Noriega F; Zambrano B
    Pediatr Infect Dis J; 2018 Nov; 37(11):1190-1191. PubMed ID: 30308599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dengue vaccine: come let's fight the menace.
    Chawla S; Sahoo SS; Singh I; Verma M; Gupta V; Kumari S
    Hum Vaccin Immunother; 2015; 11(2):474-6. PubMed ID: 25695523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Will dengue vaccines be used in the public sector and if so, how? Findings from an 8-country survey of policymakers and opinion leaders.
    Douglas DL; DeRoeck DA; Mahoney RT; Wichmann O
    PLoS Negl Trop Dis; 2013; 7(3):e2127. PubMed ID: 23516658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: A meeting report.
    Wilder-Smith A; Smith PG; Luo R; Kelly-Cirino C; Curry D; Larson H; Durbin A; Chu M; Tharmaphornpilas P; Ng LC; Sartori AMC; Luna EJA; Gubler DJ; España G; Yoon IK; Flasche S
    Vaccine; 2019 Aug; 37(36):5137-5146. PubMed ID: 31377079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of a tetravalent dengue vaccine in children in Latin America.
    Villar L; Dayan GH; Arredondo-García JL; Rivera DM; Cunha R; Deseda C; Reynales H; Costa MS; Morales-Ramírez JO; Carrasquilla G; Rey LC; Dietze R; Luz K; Rivas E; Miranda Montoya MC; Cortés Supelano M; Zambrano B; Langevin E; Boaz M; Tornieporth N; Saville M; Noriega F;
    N Engl J Med; 2015 Jan; 372(2):113-23. PubMed ID: 25365753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating the public health importance of the CYD-tetravalent dengue vaccine: Vaccine preventable disease incidence and numbers needed to vaccinate.
    Gessner BD; Wilder-Smith A
    Vaccine; 2016 Apr; 34(20):2397-401. PubMed ID: 27055020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-dengue Vaccines: From Development to Clinical Trials.
    Pinheiro-Michelsen JR; Souza RDSO; Santana IVR; da Silva PS; Mendez EC; Luiz WB; Amorim JH
    Front Immunol; 2020; 11():1252. PubMed ID: 32655561
    [No Abstract]   [Full Text] [Related]  

  • 30. A prospective cohort study to assess seroprevalence, incidence, knowledge, attitudes and practices, willingness to pay for vaccine and related risk factors in dengue in a high incidence setting.
    Martínez-Vega RA; Rodriguez-Morales AJ; Bracho-Churio YT; Castro-Salas ME; Galvis-Ovallos F; Díaz-Quijano RG; Luna-González ML; Castellanos JE; Ramos-Castañeda J; Diaz-Quijano FA
    BMC Infect Dis; 2016 Nov; 16(1):705. PubMed ID: 27887591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dengue vaccines approach the finish line.
    Edelman R
    Clin Infect Dis; 2007 Jul; 45 Suppl 1():S56-60. PubMed ID: 17582571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Symptomatic Dengue in Children in 10 Asian and Latin American Countries.
    L'Azou M; Moureau A; Sarti E; Nealon J; Zambrano B; Wartel TA; Villar L; Capeding MR; Ochiai RL; ;
    N Engl J Med; 2016 Mar; 374(12):1155-66. PubMed ID: 27007959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary Analysis of the Efficacy and Safety Trial Data of the Tetravalent Dengue Vaccine in Children and Adolescents in Colombia.
    Reynales H; Carrasquilla G; Zambrano B; Cortés S M; Machabert T; Jing J; Pallardy S; Haney O; Faccini M; Quintero J; Noriega F
    Pediatr Infect Dis J; 2020 Apr; 39(4):e30-e36. PubMed ID: 32040014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dengue vaccine pipeline: Implications for the future of dengue control.
    Schwartz LM; Halloran ME; Durbin AP; Longini IM
    Vaccine; 2015 Jun; 33(29):3293-8. PubMed ID: 25989449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Updates on Dengue Vaccine and Antiviral: Where Are We Heading?
    Norshidah H; Vignesh R; Lai NS
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccines and immunization strategies for dengue prevention.
    Liu Y; Liu J; Cheng G
    Emerg Microbes Infect; 2016 Jul; 5(7):e77. PubMed ID: 27436365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines.
    Capeding RZ; Luna IA; Bomasang E; Lupisan S; Lang J; Forrat R; Wartel A; Crevat D
    Vaccine; 2011 May; 29(22):3863-72. PubMed ID: 21477675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Challenges in the clinical development of a dengue vaccine.
    Wallace D; Canouet V; Garbes P; Wartel TA
    Curr Opin Virol; 2013 Jun; 3(3):352-6. PubMed ID: 23747120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dengue vaccines: challenges, development, current status and prospects.
    Ghosh A; Dar L
    Indian J Med Microbiol; 2015; 33(1):3-15. PubMed ID: 25559995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dengue vaccine: a key for prevention.
    Thisyakorn U; Tantawichien T
    Expert Rev Vaccines; 2020 Jun; 19(6):499-506. PubMed ID: 32452272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.